Antibody production
-
Antibody production
Antibody therapeutics in clinical trials for the treatment of COVID-19
The race for the repurposing and development of treatments for COVID-19 continues amidst conflicting data on the new strain of coronavirus. Due to the shorter developmental times in comparison to…
-
COVID-19 antibodies, antigens, and services
SARS-CoV-2 is a new Betacoronavirus responsible for the COVID-19 respiratory outbreak. The virus is also the third of the genus… Read More
-
How is antibody therapy changing the way we treat HIV?
The ever-elusive cure for human immunodeficiency virus (HIV) infection continues to be out of reach for most patients. But the… Read More
-
“Researchers are not leveraging the speed and resolution of flow cytometry for clinical evaluation”
Uniquely poised between research labs and the clinic, Professor Tomáš Kalina and his team at the Charles University in Prague,… Read More
-
“Antibodies will make a significant contribution to design effective control strategies for COVID-19”
Intrigued by how parasites are able to elude our immune system, Professor Richard Pleass from the Liverpool School of Tropical… Read More
-
5 strategies to skyrocket the potency of monoclonal antibody therapy
Every year since 2014, at least 6 new monoclonal antibody therapies enter the clinic. These molecules are designed to target… Read More
-
Fully human monoclonal antibody discovery: technologies and trends
The proportion of fully human monoclonal antibodies gaining clinical approval has quickly escalated since the approval of Humira® in 2002. Read More
-
Antibody production: hybridoma technology as the preferred method for therapeutic applications?
Up to 2019, 79 antibodies were granted approval by the FDA or EMA for clinical use in the US or… Read More
-
What essential steps are necessary to accelerate recombinant antibody expression?
Transformation or transfection are still considered one of the most challenging steps in recombinant antibody production. The choice of… Read More
-
What stimulates antibody generation and how to leverage it for the design of effective immunization strategies
Understanding what stimulates antibody production is important to improve the efficiency of both active and passive immunization strategies. Due to… Read More